Ultrafast bone scintigraphy scan for detecting bone metastasis using a CZT whole-body gamma camera
暂无分享,去创建一个
Toshihiko Ehara | Ichiei Kuji | Ichiro Matsunari | Masafumi Takahashi | K. Koga | I. Matsunari | T. Yamane | Tomohiko Yamane | Atsushi Kondo | Yuuki Miyazaki | Kenji Koga | I. Kuji | Masafumi Takahashi | Atsushi Kondo | Yuuki Miyazaki | Toshihiko Ehara
[1] S. Larson,et al. A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition , 2016, The Journal of Nuclear Medicine.
[2] Tohru Shiga,et al. Enhanced diagnostic accuracy for quantitative bone scan using an artificial neural network system: a Japanese multi-center database project , 2013, EJNMMI Research.
[3] M. Oyama,et al. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer , 2017, European Journal of Hybrid Imaging.
[4] S. Larson,et al. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] V. Treyer,et al. Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[6] K. Miwa,et al. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting , 2015, Annals of Nuclear Medicine.
[7] S M Larson,et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] M. Koyama,et al. Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups , 2017, Annals of Nuclear Medicine.
[9] M. Lomsky,et al. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer , 2016, The Journal of Nuclear Medicine.
[10] J. Mortensen,et al. 223Ra Therapy of Advanced Metastatic Castration-Resistant Prostate Cancer: Quantitative Assessment of Skeletal Tumor Burden for Prognostication of Clinical Outcome and Hematologic Toxicity , 2017, The Journal of Nuclear Medicine.
[11] I. Matsunari,et al. Quantification of osteoblastic activity in epiphyseal growth plates by quantitative bone SPECT/CT , 2018, Skeletal Radiology.
[12] Mattias Ohlsson,et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index. , 2012, European urology.
[13] C. Logothetis,et al. Osteoblasts in prostate cancer metastasis to bone , 2005, Nature Reviews Cancer.
[14] Feng Wang,et al. 68Ga-DOTA-NGR as a novel molecular probe targeting APN/CD13 for tumor angiogenesis imaging , 2013 .
[15] Valerie Treyer,et al. Nuclear Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride Detector Technique: Optimized Protocol for Scan Time Reduction , 2010, Journal of Nuclear Medicine.
[16] S. Baba,et al. Influence of the Different Primary Cancers and Different Types of Bone Metastasis on the Lesion-based Artificial Neural Network Value Calculated by a Computer-aided Diagnostic System, BONENAVI, on Bone Scintigraphy Images , 2017, Asia Oceania journal of nuclear medicine & biology.
[17] Hubert Cochet,et al. Absolute Quantification of Left Ventricular Global and Regional Function at Nuclear MPI Using Ultrafast CZT SPECT : Initial Validation Versus Cardiac MR , 2013 .
[18] M. Morris,et al. Current perspectives on bone metastases in castrate-resistant prostate cancer , 2018, Cancer and Metastasis Reviews.
[19] Stoffer Reiffers,et al. Impact of a new ultrafast CZT SPECT camera for myocardial perfusion imaging: fewer equivocal results and lower radiation dose , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[20] Markus Krönke,et al. Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using 68Ga-PSMA PET/CT , 2017, The Journal of Nuclear Medicine.
[21] P. Pretorius,et al. SPECT/CT: an update on technological developments and clinical applications. , 2018, The British journal of radiology.